ADVERSE DRUG REACTIONS (ADRs) TO LEVETIRACETAM (LEV): A CASE SERIES AND CLINICAL INSIGHTS
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 3
- 试验地点
- 1
- 主要终点
- 1. To report three probable cases of rare and unexpected adverse drug reactions with Levetiracetam (LEV)
研究概览
简要总结
All three adverse drug reactions to Levetiracetam drug, are unexpected and rare. The main aim of presenting this case series is to disseminate existing and newly gained knowledge about the side-effect profile of LEV., which will help in identifying some serious and preventable ADRs, and thus improve patient safety and outcomes.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50.00 Year(s) 至 90.00 Year(s)（—）
- 性别
- All
入选标准
- •To report three probable cases of rare and unexpected adverse drug reactions with Levetiracetam (LEV)
- •To do ADR causality assessment of all the three cases.
- •Patients on LEV treatment who have developed adverse drug reactions.
排除标准
- •Patients not treated with Levetiracetam.
结局指标
主要结局
1. To report three probable cases of rare and unexpected adverse drug reactions with Levetiracetam (LEV)
时间窗: 1. To report three probable cases of rare and unexpected adverse drug reactions with Levetiracetam (LEV) | 2. To do ADR causality assessment of all the three cases within 10 days to 1 month of taking the drug
2. To do ADR causality assessment of all the three cases.
时间窗: 1. To report three probable cases of rare and unexpected adverse drug reactions with Levetiracetam (LEV) | 2. To do ADR causality assessment of all the three cases within 10 days to 1 month of taking the drug
次要结局
- To check for other Adverse drug reactions due to the drug Levetiracetam(10 days & 1 month)
研究者
Dr PRIYANKA S
KIMS, Bangalore